The Chip Index Has Been Slashed, but These 3 Stocks Have a Path Back

14 of 30 Philadelphia Semiconductor Index members are down over 50%. Microchip Technology (MCHP) is down 70% from its high, with supply issues affecting its recovery. Teradyne (TER) fell 31.3% after earnings, relying on 2027 customer ramps. STMicroelectronics (STM) is down 78.3% YTD, aiming for margin recovery by closing old fabs. Microchip is seen as having the clearest path back.

Original reporting
Published Nov 13, 2026, 2:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 2:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Chip Index Has Been Slashed, but These 3 Stocks Have a Path Back — source image
Decision brief

The 30-second read

$MCHPBearishLow
01

Why it matters

Provides a qualitative assessment of each company's near‑term risk and longer‑term upside.

02

Market read

Highlights the divergent recovery timelines for three chip stocks, useful for sector rotation decisions.

03

What to watch

Potential impact of upcoming regulatory export controls on equipment sales.

Relevance 4/10Novelty 2/10Timing: post‑earnings analysis

Background

The article reviews three semiconductor stocks that have fallen sharply and outlines the specific catalysts needed for recovery.

Company-level read

Ticker impact

$MCHPBearishMedium confidence
Context

Microchip Technology guidance cut and capacity constraints highlighted as downside catalysts.

Expected impact

likely downward pressure as investors price in lower guidance and margin risk

Evidence & confidence

The article notes a sequential revenue dip guidance and a six‑to‑32‑week lead time, which typically depresses the stock until the backlog converts to revenue.

$TERNeutralMedium confidence
Context

Teradyne's record quarter and future hyperscaler capacity ramps are discussed as recovery drivers.

Expected impact

moderate pressure until concrete capacity commitments materialize

Evidence & confidence

The article emphasizes that the key catalyst is years away, so short‑term sentiment remains cautious.

$STMNeutralMedium confidence
Context

STMicroelectronics' fab closures and margin improvement plan are examined as future catalysts.

Expected impact

potential downside risk if restructuring delays occur

Evidence & confidence

The piece points out that the restructuring timeline extends into 2027‑28, keeping investors wary.

Market effects

Semiconductor sector remains volatile as AI demand outpaces capacity.

US chip makers face short‑term pressure from supply constraints.

Global AI‑driven demand stresses chip supply chains worldwide.

Counterpoint

Stocks may hold steady if capacity expansions accelerate faster than expected.

Key entities

  • Microchip Technology

    Semiconductor maker facing capacity constraints.

  • Teradyne

    Test equipment supplier awaiting hyperscaler ramps.

  • STMicroelectronics

    Fab restructuring target for margin improvement.

Related articles

$005930.KSHighAI 9/10

Samsung will make SpaceX Starlink chips at its Austin fab in a $1.9 billion expansion, Korean paper reports

Samsung plans a $1.9B expansion of its Austin fab to produce chips for SpaceX's Starlink satellites, reports Seoul Economic Daily. The chips, STM32V8 microcontrollers, are used in Starlink's inter-satellite laser links. Samsung declined to confirm customer contracts. The expansion aligns with Samsung's CHIPS Act award for FD-SOI chip production.

$TERHigh

Teradyne and FormFactor jump after Jefferies starts coverage with Buy ratings

Jefferies initiated coverage of Teradyne and FormFactor with Buy ratings, citing their roles in AI-driven chip testing. Teradyne's stock rose 8.3% to $265.78, with a $284 target, while FormFactor gained 11.9% with a $102 target. Jefferies projects significant growth in the automated test equipment market, with Teradyne's revenue potentially rising from $1.9B to $6.9B by 2030. Both companies have seen recent pullbacks but reported strong AI-related revenue growth.

$TERHigh

Teradyne's AI testing opportunity prompts Jefferies 'buy' rating

Jefferies initiated coverage of Teradyne (NYSE:TER) with a Buy rating and $284 price target, citing AI-driven demand. The broker forecasts semiconductor testing market growth to $25B by 2030, with Teradyne's SoC testing revenue rising to $6.9B. Teradyne's shares fell 53% from summer highs, which Jefferies sees as an entry point. The bank expects Teradyne to gain market share and benefit from Nvidia's (NASDAQ:NVDA) adoption of dual sourcing.

$TERHigh

Why is Teradyne stock surging today?

Teradyne (TER) stock rose 8% in pre-market trading after Jefferies initiated coverage with a Buy rating and $284 price target, citing AI-driven growth. Analysts expect the semiconductor test equipment market to expand significantly, with TER benefiting from increased system-on-chip testing. The company's Q3 2026 earnings beat consensus, and broader tech sector gains also supported the surge.